Sort
82,697 grants matching “vaccine development”
HIV-1 Envelope Glycoproteins
$836,610Joseph G Sodroski · Dana-Farber Cancer Inst · R37 · FY2014 · AI
Cholera Transmission in Gressier Region, Haiti
$836,598John Glenn Morris · University Of Florida · R01 · FY2014 · AI
Cytokines in AIDS and Cancer
$836,568George N. Pavlakis · Division Of Basic Sciences - Nci · ZIA · FY2010 · CA
The Environmental Determinants of Diabetes in Youth: Washington Clinical Center
$836,415William A. Hagopian · Pacific Northwest Research Institute · U01 · FY2010 · DK
New Approaches To Active Immunoprophylaxis
$836,285Robert H. Purcell · National Institute Of Allergy And Infectious Diseases · Z01 · FY2008 · AI
DRW HIV-Ab/HCV-Ab/HBsAg Triplex Rapid Test Submission for FDA-PMA Approval
$836,222Helen H Lee · Diagnostics For The Real World, Ltd · R44 · FY2011 · HL
Optical Chip Test for T Cell Function in HIV Patients
$836,212Ngimat Company · R44 · FY2004 · AI
Nucleoside modified mRNA based HIV vaccine
$836,210Drew Weissman · University Of Pennsylvania · R01 · FY2019 · AI
Animal Medicine COVID Support
$836,137Mario Roederer · National Institute Of Allergy And Infectious Diseases · ZIG · FY2024 · AI
Functionally distinct human CD4 T cell responses to novel evolutionarily selected M. tuberculosis antigens
$836,129Joel D. Ernst · University Of California, San Francisco · R01 · FY2025 · AI
Human Antibodies to HIV
$836,099Michel C Nussenzweig · California Institute Of Technology · P01 · FY2016 · AI
Immune determinants modulating cancer development in Lynch Syndrome
$836,028Nina Bhardwaj · Icahn School Of Medicine At Mount Sinai · UG3 · FY2024 · CA
Immune determinants modulating cancer development in Lynch Syndrome
$836,028Nina Bhardwaj · Icahn School Of Medicine At Mount Sinai · UG3 · FY2025 · CA
Cancer Vaccines and Modulation of Checkpoint Controls in Immunization
$835,947John Janik · Division Of Basic Sciences - Nci · ZIC · FY2009 · CA
Small molecule-induced degradation of dengue proteins as an antiviral strategy
$835,944Priscilla Li-Ning Yang · Stanford University · R01 · FY2024 · AI
Small molecule-induced degradation of dengue proteins as an antiviral strategy
$835,944Priscilla Li-Ning Yang · Stanford University · R01 · FY2023 · AI
An HIV Prevention Program for Mochudi, Botswana
$835,915Myron E Essex · Harvard School Of Public Health · R01 · FY2009 · AI
Exploiting sites of vulnerability on influenza viruses
$835,902Ian A Wilson · Scripps Research Institute, The · R56 · FY2015 · AI
RNA Metabolism in Trypanosomes
$835,872Christian Tschudi · Yale University · R01 · FY2016 · AI
Proteomics Core: Systems Biology to Identify Biomarkers of Neonatal Vaccine Immunogenicity
$835,849Hanno Steen · Boston Children'S Hospital · U19 · FY2018 · AI
Clinical trials employing cancer vaccine combination therapies
$835,822James L. Gulley · Division Of Basic Sciences - Nci · ZIA · FY2018 · CA
Cancer Therapy Clinical Trials Using Novel Recombinant Vaccines
$835,822James L. Gulley · Division Of Basic Sciences - Nci · ZIA · FY2018 · CA
Identification of human tumor-associated antigens
$835,772Kwong Yok Tsang · Division Of Basic Sciences - Nci · ZIA · FY2013 · CA
Inflammation and Therapy for Respiratory Virus Infection
$835,734Helene Rosenberg · Niaid Extramural Activities · Z01 · FY2007 · AI
AAV-mediated delivery of eCD4-Ig for prevention and treatment of perinatal HIV infection
$835,519Mauricio De Aguiar Martins · Scripps Florida · R01 · FY2020 · HD